John M. Reher created the Brain Trust Accelerator Fund in 2006. The goal of this venture capital fund is to earn an attractive rate of return by creating and investing in early-stage medical companies that address brain-related diseases. The general partner of the fund directs a portion of its carried interest to brain disease charities, which provide deal flow and advisory services.

From 2001-2006, John was founding president and executive director of Accelerate Brain Cancer Cure, Inc. (ABC2), a non-profit organization dedicated to accelerating therapies for treatment of brain cancer by employing venture principles to this philanthropic endeavor. Previously, John had more than 12 years of venture capital experience as a general partner and co-founder of Medicus Venture Partners, an early-stage healthcare venture partnership with investments that included Biosite Diagnostics, Inhale Therapeutic Systems (now Nektar), Tularik, and other successful companies.

Before entering the venture industry in 1989, John held financial, marketing, licensing, acquisitions and overall team leader positions at Genentech (1982-1989) and at G.D. Searle Pharmaceuticals (1974-1981).

John has taught college level courses in Economics, Finance and Investments. He received a Masters of Management degree from Northwestern University and a BS in Mathematics and Business Economics from Illinois Benedictine University.